Market Research Logo

Irritable Bowel Syndrome Pipeline Highlights – 2017 Update

1. Irritable Bowel Syndrome Pipeline by Stages
2. Irritable Bowel Syndrome Pipeline by Drug Class
3. Irritable Bowel Syndrome Pipeline by Company
4. Irritable Bowel Syndrome Phase 3 Clinical Trial Insights
5. Irritable Bowel Syndrome Phase 2 Clinical Trial Insights
6. Irritable Bowel Syndrome Phase 1 Clinical Trial Insights
7. Irritable Bowel Syndrome Preclinical Research Insights
8. Irritable Bowel Syndrome Discovery Stage Insights
9. Appendix
10. Research Methodology
LIST OF TABLES
Table 1: Irritable Bowel Syndrome Phase 3 Clinical Trials, 2017
Table 2: Irritable Bowel Syndrome Phase 2 Clinical Trials, 2017
Table 3: Irritable Bowel Syndrome Phase 1 Clinical Trials, 2017
Table 4: Irritable Bowel Syndrome Preclinical Research, 2017
Table 5: Irritable Bowel Syndrome Discovery Stage, 2017
LIST OF FIGURES
Figure 1: Irritable Bowel Syndrome Pipeline Molecules by Clinical Trials Stage, 2017
Figure 2: Irritable Bowel Syndrome Pipeline Molecules by Drug Class, 2017
Figure 3: Irritable Bowel Syndrome Pipeline Molecules by Company, 2017
Figure 4: Irritable Bowel Syndrome Phase 3 Clinical Trial Highlights, 2017
Figure 5: Irritable Bowel Syndrome Phase 2 Clinical Trial Highlights, 2017
Figure 6: Irritable Bowel Syndrome Phase 1 Clinical Trial Highlights, 2017
Figure 7: Irritable Bowel Syndrome Preclinical Research Highlights, 2017
Figure 8: Irritable Bowel Syndrome Discovery Stage Highlights, 2017

Irritable Bowel Syndrome Pipeline Highlights – 2017 Update

The latest report from Fore Pharma, Irritable Bowel Syndrome Pipeline Highlights – 2017 Update, provides most up-to-date information on key pipeline products in the global Irritable Bowel Syndrome market. It covers emerging therapies for Irritable Bowel Syndrome in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:
The report provides Irritable Bowel Syndrome pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:
The report provides Irritable Bowel Syndrome pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:
The report provides Irritable Bowel Syndrome pipeline products by the company.

Short-term Launch Highlights:
Find out which Irritable Bowel Syndrome pipeline products will be launched in the US and Ex-US till 2020.

SUMMARY:

  • Irritable Bowel Syndrome phase 3 clinical trial pipeline products
  • Irritable Bowel Syndrome phase 2 clinical trial pipeline products
  • Irritable Bowel Syndrome phase 1 clinical trial pipeline products
  • Irritable Bowel Syndrome preclinical research pipeline products
  • Irritable Bowel Syndrome discovery stage pipeline products
  • Irritable Bowel Syndrome pipeline products short-term launch highlights


Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

;